Gene Silencing/Gene Editing
News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
Careviso Closes $17.4M Series B Funding Round
The startup company, formerly called CMT Solutions, has developed software to automate prior authorization for diagnostic testing.
The test can be prepared in a lateral flow format, requires no additional instruments, and can be run in at-home settings.
Beyond COVID-19, Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System
Proof Diagnostics recently submitted a CRISPR-based, point-of-care test for SARS-COV-2 to the US Food and Drug Administration for Emergency Use Authorization.
Jumpcode Genomics, TGen Partner to Test Metagenomic Approaches for COVID Detection
The company and institute are collaborating on the development of a diagnostic assay that uses Jumpcode's CRISPR-based reagents and TGen's NGS technology.
The point-of-care system can detect SARS-CoV-2 in unprocessed patient saliva in about an hour, according to the researchers.